Clinical management of children diagnosed with HIV and hepatitis C virus infection

(1)

HOST-PATHOGEN

INTERACTIONS

IN

CHRONIC

INFECTIONS

4

th

_D

OMINIQUE

DORMONT

I

NTERNATIONAL

C

ONFERENCE

M

ATERNAL

C

HRONIC

V

IRAL

I

NFECTIONS

T

RANSMITTED

TO THE

I

NFANTS

:

FROM

M

ATERNAL

CHRONIC

VIRAL

I

NFECTIONS

TRANSMITTED

TO THE

I

NFANTS

:

FROM

P

ARIS

,

V

AL DE

G

RÂCE

(2)

W

ELCOME

A

DDRESSES

Welcome to the 4th_{International Dominique Dormont Conference}

On behalf of the Organizing Committee, we are pleased to welcome you in Paris for the fourth Dominique Dormont International Conference. This annual conference is in memory of the spirit of Dominique Dormont and his dedication to research on pathogenesis and treatment of chronic infectious diseases.

The topic of this fourth event is "Maternal chronic viral infections transmitted to the infants: from mechanisms to prevention and care". It is devoted to cover mother-to-child transmission and pediatric viral infections, such as Human Cytomegalovirus, Hepatitis C Virus and Human Immunodeficiency Virus, and also other chronic infectious agents, close to Dominique Dormont's wide interest. The topics of the sessions selected by the organizing committee span from basic research to prevention and therapy. Attention is given to viral and host determinants of mother-to-child transmission,as well as means of prevention and control of transmission and disease in children, with drugs, immunotherapy and vaccine. Emphasis is also on the immunological development of host defences at the maternal-fetal interface and, in the newborn, basic concepts to understand pathogenesis and clinical outcome. The interaction between basic scientists and clinicians interested in different pathogens is intended to encourage the exchange of knowledge and foster new collaborations.

Each session is introduced by a keynote lecture by an expert in the field followed by abstract driven presentations. An effort has been made for encouraging presentations from young investigators. An international Scientific Committee has selected the abstracts for this programme giving priority to original unpublished studies to share exciting and recent results. The poster sessions are a further opportunity for stimulating exchanges between senior and young scientists and clinicians. Scholarships have been selected according to the quality of the abstracts and allocated to fellows from resource limited countries. To facilitate interdisciplinary discussions we have limited the attendance to a group of 200 participants.

We hope you will enjoy your stay in Paris.

Elisabeth MENU, Gabriella SCARLATTI and Daniel BEQUET

(3)

O

RGANIZING

C

OMMITTEE Chair and Co-Chairs:

E. Menu G. Scarlatti D. Béquet

Core Local Organizing committee:

F. Barré-Sinoussi D. Béquet P. Clayette H. Fleury G. Gras J. Grassi G. Inchauspé R. Le Grand E. Menu N. Tordo

Extended Local Organizing committee:

B. Bazin G. Chaouat F. Dabis A. De Rossi A. Faye P. Goulder Y. Rivière C. Rouzioux G. Scarlatti P.A. Tovo P. Van de Perre M. Wainberg B. Bigot C. Bréchot A. Bugat J.C. Chermann M.F. Courel L. Court J-F. Delfraissy A. Georges

L. Di Giamberardino M. Hirsch J.M. Huraux M. Kazatchkine P. Kourilsky J.P. Lévy J. Marimbert

I

NTERNATIONAL

S

CIENTIFIC

P

ROGRAMME

C

OMMITTEE

E

MERITUS

C

OMMITTEE

G. Biberfeld(SE)

S. Blanche(F)

P. Brandtzaeg(N)

P. Cahn(AR)

H. Coovadia(ZA)

C. Courpotin(F)

C. Davrinche(F)

D. Ekouevi(CI)

R. Ekpini(USA)

C. Giaquinto(I)

G. John-Stewart(USA)

M. Lallemant(TH)

P. Lepage(B)

T. Li(CN)

M. Marthas(USA)

P. Mayaud(UK)

J. McIntyre(ZA)

N. Meda(BF)

L. Mofenson(USA)

M. Morgado(BR)

P. Msellati(F)

A. Munoz-Fernandez(ES)

P. Musoke(UG)

L. Pembrey(UK)

I. Penda(CM)

P. Rossi(I)

F. Rouet(F)

Y. Ville(F)

C. Wilfert(USA)

(4)

A

CKNOWLEDGEMENTS

The Organizing Committee wishes to extend its thanks and appreciation to :

■ The following sponsors for their contributions: • ANRS

101, rue de Tolbiac 75013 Paris www.anrs.fr

• Biomérieux

Chemin de l’Orme 69280 Marcy l’Etoile www.biomerieux.fr

• Bio-Rad

3, boulevard Raymond Poincaré 92430 Marnes la Coquette www.bio-rad.com

• Boehringer-Ingelheim France

BSPM

12, rue André Huet - BP 292 51060 Reims cedex

www.boehringer-ingelheim.fr

• CEA/SACLAY

Direction des Sciences du Vivant 91191 Gif sur Yvette Cedex www.cea.fr

• Fondation Mérieux

17, rue Bourgelat 69002 Lyon

www.fondation-merieux.org

• Gilead

100, avenue de Suffren 75015 Paris

www.gilead.com

(5)

• National Institute of Health

Office of AIDS Research 5635 Fishers Lane, suite 4000, room 4016 D Bethesda, MD20892 USA

www.nih.gov

• Sanofi Pasteur

2, avenue Pont Pasteur 69367 Lyon cedex 07 www.sanofipasteur.fr

• Schering-Plough

92, rue Baudin 92307 Levallois-Perret www.schering-plough.com

• Spi-Bio

CEA

18, route du Panorama BP6

92265 Fontenay aux Roses cedex www.spibio.com

• Tibotec, Division Janssen-Cilag

1, rue Camille Desmoulins

92787 Issy les Moulineaux Cedex 9 www.tibotec-vih.fr

■ Mrs Elisabetta FARINAfor the illustration of the conference.

■ The World Health Organization, Department of Reproductive

(6)

T

HURSDAY

,

D

ECEMBER

13

17:00

Opening Ceremony

Chairs:P. Miotti, F. Dabis Welcome addresses

J.E. Touze,Directeur de l’Ecole du Val de Grâce

E. Menu , G. Scarlatti, D. Béquet,chairs of the conference

Introductory lecture L1 17:15 Great challenges to PMTCT in the South: The role of the

developed nations in supporting strategies that work

D. Onyango

Session

1 a

Viral and maternal determinants of mother to

child transmission (MTCT) of chronic viral

infections

Chairs:A. Ayouba, C. Davrinche

Keynote Lecture L2

17:45 Virologic and host determinants of breastfeeding transmission of human retroviruses

P. Van de Perre

P

ROGRAMME OF THE

C

ONFERENCE

M

ATERNAL

C

HRONIC

V

IRAL

(7)

Oral presentations

18:15 Primary HIV-1 infection during pregnancy: high rate of HIV-1 MTCT in a cohort of patients in southern Brazil Nielsen-Saines K., Melo M., Varella I., Fonseca R., Lira R., Turella M.L., Canti I., Campello C., Moreira A.M.,

Riegel Santos B. O1

18:30 Role of R5 phenotypic variation in mother-to-child transmission of HIV-1

Cavarelli M., Karlsson I., Zanchetta M., Antonsson L., Plebani A., Giaquinto C., Fenyo E.M., De Rossi A., Scarlatti G. O2 18:45 Bile-salt stimulated lipase in human milk binds DC-SIGN

and inhibits HIV-1 transmission

Stax M., Naarding M., Speijer D., Hernell O., Pollakis G.,

Paxton W. O3

19:00 Human herpesvirus 8 (HHV-8) " in vitro" infection of human placental histocultures

Di Stefano M., Calabro M.L., di Gangi I.M., Cantatore S.,

Barbierato M., Chieco-Bianchi L., Grecos P., Gesualdo L., Menu E.,

Fiore J.R. O4

19:00 HIV-1 internalization in polarized human trophoblasts occurs through a peculiar endocytic pathway

Tremblay M.J., Vidricaire G. O5

(8)

Session

1 b

Viral and maternal determinants of mother to child

transmission (MTCT) of chronic viral infections

Chairs:G. Biberfeld, G. Chaouat

9:00 Determinants of maternal infection associated with virus infection of the fetus and newborn infant

W. Britt

9:30 A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27

Plancoulaine S., Gessain A., Tortevoye P., Boland-Auge A.,

Vasilescu A., Matsuda F., Abel L. O6 9:45 Influence of pregnancy on the specificity and breadth of

antigen recognition by HIV-specific cytotoxic T lymphocytes Jolette E., Samson J., Lapointe N., Boucher M., Soudeyns H. O7 10:00 HCV-Specific T-cell Responses during Acute Hepatitis C Virus

Infection in Pregnancy

Honegger J., Prasad M., Colombo D., Bowen D., Walker C. O8 10:15 Toxoplasmosis reactivation following HAART introduction

associated with foetal death in a severely immune suppressed HIV-infected woman: An Immune reconstitution inflammatory syndrome (IRIS) consequence?

Caby F., Lemercier D., Touafek F., Paris L., Grigorescu R.,

Gonzales M., Carcelain G., Pauchard M., Canestri A., Katlama C., Dommergues M., Tubiana R. O9

10:30 Coffee break and poster viewing

(9)

Session

2 Role of co-infections in MTCT

Chairs:L. Pembrey, P. Msellati

11:00 Mechanisms by which co-infections modify HIV-1 transmission

G. John-Stewart

11:30 High prevalence of cytomegalovirus (CMV) infection in infants born to HIV infected mothers–ANRS French Perinatal Cohort (EPF)

Guibert G.,Leruez-Ville M., Rouzioux C., Tubiana R., Mandelbrot L., Blanche S., Teglas J.P., BenMebarek Y., Le Chenadec J.,

Warszawski J., ANRS French Perinatal Cohort (EPF) O10 11:45 Hepatitis C virus quasispecies evolution during pregnancy

and between consecutive pregnancies: influence of maternal immune responses

Troesch M., Meunier I., Lepage C., Samson J., Lapointe N.,

Boucher M.,Soudeyns H. O11

12:00 Risk factors for Human Cytomegalovirus (HCMV) infection in infants born to HIV-1 infected mothers in Thailand

Khamduang W., Sirirungsi W., Jourdain G., Leurent B., McIntosh K., Pagdis K., Somsamai R., Sirinontakan S., Hinjiranandana T.,

Ardong W., Lallemant M., Ngo-Giang-Huong N. O12 12:15 Co-infection with Trypanosoma cruzi (Chagas´ disease agent)

decreases HIV-1 transcription in human placenta Dolcini G., Solana M.E., Andreani G., Celentano A.M.,

Donato A.M., Del Rio A., Martinez Peralta L. O13 12:30 Plasmodium falciparum and placental cytokine profiles

(10)

Session 3

Prevention and control of MTCT: from antivirals

through immunotherapy and vaccine

Chairs:M. Marthas, D.K. Ekouevi

14.00 Mother-to-Child Transmission of Persistent Viral Infections: Pathogenesis and Prevention

K. Luzuriaga

14.30 VSV/MVA vaccine rapidly elicits SIV antibodies and local & systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge

Abel K., Van Rompay K.K., Eastlick J., Moore J., Lemieux M., Schmidt K., Earl P., Buonocore-Buzzelli L., Moss B., Rose N.,

Rose J., McChesney M.B., Kozlowski P.,Marthas M.L. O15 14.45 Is access to care different for women from sub-Saharian Africa

than for French women according to prevention of mother-to-child HIV transmission in France?

Jasseron C., Warszawski J., Blanche S., Rouzioux C., Le Chenadec J., Dolfus C., Faye A., Hamrene K., Teglas J.P.,

Tubiana R., Mandelbrot L., ANRS French Perinatal Cohort (EPF) O16 15.00 Prevention of mother-to-child transmission of HIV-1 through

breastfeeding by treating infants or mothers prophylactically with antiretrovirals in Dar es Salaam, Tanzania. The MITRA and MITRA PLUS studies

Kilewo C., Karlsson K.,Ngarina M., Massawe A., Lyamuya E., Lipyoga R., Msemo G., Bakari M., Swai A., Mhalu F., Biberfeld G. O17 15.15 Prevalence of HIV-1 drug resistance mutations in antiretroviral

naïve pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam

Ayouba A., Le Fouler L., Lien T., Ly N., Maréchal V., Vessière A., Kfutwah A., Reynes J.M., Menu E., Nerrienet E., Vray M.,

Fleury H., Barré-Sinoussi F. O18 15.30 Low birth weight is associated with maternal Nevirapine based

antiretroviral therapy in Abidjan, Côte d’Ivoire: The Ditrame Plus project and MTCT-Plus initiative (2001-2007)

Coffie P., Becquet R. , Tonwe-Gold B., Horo A., Touré P.,

(11)

15.45 Tolerance and viral resistance after single-dose nevirapine and short course of tenofovir disoproxil fumarate and emtricitabine to prevent mother-to-child transmission of HIV-1: the TEmAA ANRS 12109 Phase II Trial, Step 1

Arrivé E., Blanche S., Chaix M.L., Nerrienet E., Rouzioux C.,

McIntyre J., Gray G., Coffié P., Kruy Sim L., Ekouévi D., Dabis F. O20

Session 4

Immunological development and host defences in

neonates and children

Chairs :M. Morgado, P. Rossi

16:30 Neonatal adaptation of the immune system

P. Brandtzaeg

17:00 Microtransfusion and viral exposure in uninfected infants born to HIV-infected women

Warning J., Ziegler J., French R. O21 17:15 Frequency of HIV-specific CD8 T lymphocytes is inversely

correlated to HIV DNA levels in untreated infected children Buseyne F., Blanche S., Burgard M., Milliancourt C.,

Scott-Algara D., Rouzioux C., Rivière Y. O22 17:30 Primary CMV infection: a co-factor for HIV-1 disease

progression in African infants?

Slyker J.A., Payne B.L.,John-Stewart G.C., Obimbo E., Emery S., Richardson B., Dong T., Mbori-Ngacha D., Overbaugh J.,

(12)

Session 5

Diagnosis, monitoring and treatment of infected

children

Chairs:E. Nerrienet, N. Ngo-Giang-Huong

9:00 Natural history of vertically acquired HCV infection

P.A. Tovo

9:30 Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)

Avettand-Fenoel V., Chaix M.L., Blanche S., Burgard M.,

Warszawski J., Rouzioux C. O24 9:45 Early versus deferred highly active antiretroviral therapy in

HIV infected infants: a European collaborative cohort study Goetghebuer T., Haelterman E., Le Chenadec J., Dollfus C., Gibb D., Boyd K., Judd A., Gallis L., Gabianos C., Ramos J., Thorne C., Marczynska M., Keiser O., Ene L., Hainaut M., Scherpbier H., Wintergerst U., Schmitz V., Verweel G.,

Giaquinto C., Warszawski J., Levy J. O25 10:00 Once-a-day pediatric HAART with DDI+3TC+EFV in Burkina Faso.

A phase II Trial (ANRS 12103 trial)

Msellati P., Nacro B., Zoure E., Hien H., Tamboura H., Rouet F., Diagbouga S., Ouiminga A., Drabo A., Yaméogo S., Peyrière H., Mathieu O., Nicolas J., Van de Perre P. O26

(13)

10:15 Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants

Prendergast A., Mphatswe W., Tudor-Williams G.,

Blanckenberg N., Cengimbo A., Jeena P., Rakgotho M., Pillay V., Thobakgale C., Reddy S., Mncube Z., Vanderstok M., McCarthy N., Dong C., Coovadia H., Morris L., Walker B.D., Goulder P. O27 10:30 Virus phenotype variability during disease progression of

HIV-1 infected children

Cavarelli M.,Dispinseri S., Ripamonti C., Karlsson I.,

Antonsson L., Plebani A., Fenyo E.M., Scarlatti G. O28

11:15

Closing ceremony

Chairs:S. Blanche, C. Rouzioux

Concluding remarks

F. Barré-Sinoussi

Memorial lecture L8 Main infections in the children under 5 years old in developping countries: reports and perspectives

C. Courpotin

Welcome to the DDIC 2008

S. Blanche, C. Rouzioux

12:15 Closing of the conference

(14)

P

OSTERS

Session

1

P1 A guinea pig model for Cytomegalovirus congenital infection: dose-effect and vertical transmission rate

Benoist G., Ville Y., Rouzioux C., Delezoide A.L., Flori P., Leruez-Ville M.

P2 Transmission of Hepatitis B Virus Infection is Predominantly Perinatal in the Indian Subcontinent

Hissar S., Manoj K., Syed N K., Sanjay S., Kumar G.T., Ranjeet C., Didar S., Puja S., Shiv K S.

P3 Preventable zidovudine overdose during post-natal prophylaxis in healthy children born to HIV-1-positive mothers

Chiappini E.

P4 Genetically Engineered Live-Attenuated Cytomegalovirus (CMV) Vaccines Improve Pregnancy Outcome in the Guinea-Pig Model of Congenital CMV Infection

Schleiss M., McGregor A., Choi Y., Anderson J., Leviton M., Cui X., McVoy M.

P5 Characteristics of HIV-1 gp120 env sequences in mother-child pairs infected with HIV-1 subtype CRF01_AE

Samleerat T., Braibant M., Jourdain G.,Moreau A., Ngo-Giang-Huong N., Leechanachai P., Hemvuttiphan J., Hinjiranandana T., Changchit T., Warachit B., Suraseranivong V., Lallemant M., Barin F.

P6 Factors affecting mother to child transmission of HIV in Moungo division, Cameroon: a pilot study

(15)

P7 In vitro HIV-1 infection of human uterine mucosa during pregnancy

Marlin R., Nugeyre M.T., De Truchis C., Berkane N., Gervaise A., Scott-Algara D., Barré-Sinoussi F., Menu E.

P8 Permissivity to HCMV infection in early and term human placentae with a new ex vivo model of histocultures Casper C., Lopez H., Al Saati T., Dugas Neulat I., Berrebi A., Davignon J.L., Davrinche C.

Session

2

P9 A Plasmodium falciparum antigen increases HIV-1 replication in a human placenta-derived cell line

Ayouba A., Badaut C., Kfutwah A., Cannou C., Juillerat A., Gangnard S., Behr C., Mercereau-Puijalon O., Bentley G.A., Barré-Sinoussi F., Menu E.

Session

3

P10 Mother-to-Child transmission of HIV-1 drug resistance in a French cohort

Benizri F., Schneider V., Kara A., Guessant S., Marcelin A.G., Tubiana R., Tabone M.D., Hervé F., Vaudre G., Dehee A., Leverger G.,Dollfus C.

P11 Successful reduction of mother-to-child transmission of HIV-1 by nevirapin and non-breastfeeding in Hanoi and Haiphong Ha T.T.T., Pham L.T., Nguyen H.B., Nguyen M.A., Cam P.D., Chiodi F., Ehrnst A.

P12 Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother to child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil

Pilotto J.H., Grinsztejn B., Veloso V., Couto-Fernandez J.C.,

Rodrigues-Pedro A., Flores G., Ribeiro J.E., Lima E., Khalili R., Muri S., Ismerio R.,Morgado M.

(16)

Resource-P14 Impact of Highly Active Antiretroviral Therapy on clinical outcomes of vertically HIV-1 infected children

Palladino C., Bellon J.M., Da-Az Munoz L., Garcia Alonso D., Munoz-Fernandez M.

Session

4

P15 Age-related standards for CD4+ T-lymphocytes in healthy non-infected infants born to HIV-1 non-infected mothers from AMATA study in Rwanda

Ndayisaba G.F., Cyaga N.P., Rutanga C., Havuga E., Omes K.C., Peltier C.A.

P16 The switch from the standard proteasome to the

immunoproteasome in the mononuclear cells of children with vertically acquired HCV infection

Alfarano A., Versace A., Bertolotto G., Vatrano S.,Tovo P.A.

P17 Alterations in immunoglobulin levels in uninfected children born to HIV infected women

Bunders M.J., Pembrey L., Kuijpers T., Newell M.L.

P18 The evolution of vertically acquired HCV infection

Versace A., Mignone F., Lazier L., Gabiano C., Scolfaro C., Alfarano A.,Tovo P.A.

P19 Hepatitis B vaccine efficacy in HCV vertical infected infants Aniszewska M., Kowalik-Mikolajewska B., Pokorska-Lis M.

P20 Immunological response in congenital cytomegalovirus infection Freda E.D., Romiti M.L., LiPira G., Casciano F., Simonetti A.,

Manca F., Krzysztofiak A., Rossi P., D'Argenio P., Cancrini C.

Session

5

P21 Surveillance of perinatal AIDS and HIV diagnoses in France Lot F., Cazein F., Pillonel J., Pinget R., Semaille C.

P22 Early Diagnosis of HIV-1 infection in Cambodian infants

Ngin S., Kruy L.S., Segeral O., Horm S.V., Ek M.L., Im S., Ouk V., Ung V., Marcy O., Rouzioux C., Delfraissy J.F., Nerrienet E.

(17)

P24 Effectiveness of a early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants

Van der Linden D., Hainault M., Goetghebuer T., Haelterman E., Schmitz V., Maes P., Peltier A., Levy J.

P25 Clinical management of children diagnosed with HIV and Hepatitis C virus infection

(18)

I

NDEX

A

Abel K. O15 Abel L. O6 Al Saati T. P8 Alfarano A. P16, P18 Anderson J. P4 Andreani G. O13 Aniszewska M. P19 Antonsson L. O2, O28 Ardong W. O12 Arrivé E. O20 Avettand-Fenoel V. O24 Ayouba A. O14, O18, P9

B

Badaut C. P9 Bakari M. O17 Barbierato M. O4 Barin F. P5

Barré-Sinoussi F. O14, O18, P7, P9 Becquet R. O19

Behr C. P9 Bellon J.M. P14, P23 BenMebarek Y. O10 Benoist G. P1 Bentley G.A. P9 Berkane N. P7 Berrebi A. P8 Bertolotto G. P16 Biberfeld G. O17

Blanche S. O10, O16, O19, O20, O22, O24 Blanckenberg N. O27

Boland-Auge A. O6 Boucher M. O7, O11 Bowen D. O8 Braibant M. P5 Brandtzaeg P. L6 Britt W. L3 Bunders M.J. P17 Buonocore-Buzzelli L. O15 Burgard M. O22, O24 Buseyne F. O22

C

(19)

Chaix M.L. O20, O24 Changchit T. P5 Chiappini E. P3 Chieco-Bianchi L. O4 Chiodi F. P11 Choi Y. P4 Coffié P. O19, O20 Colombo D. O8 Coovadia H. O27 Courpotin C. L8 Couto-Fernanez J.C. P12 Cui X. P4 Cyaga N.P. P15

D

Da-Az Munoz L. P14 Dabis F. O19, O20 Dargenio P. P20 Davignon J.L. P8 Davrinche C. P8 De Rossi A. O2 De Truchis C. P7 De Vincenzi I. P13 Dehee A. P10 Del Rio A. O13 Delfraissy J.F. P22 Delzoide A.L. P1 Di Gangi I.M. O4 Di Stefano M. O4 Diagbouga S. O26 Diaz Munoz L. P23 Didar S. P2 Dispinseri S. O28 Dolcini G. O13

Dolfus C. O16, O25, P10 Dommergues M. O9

Donato A.M. O13 Dong C. O27 Dong T. O23 Drabo A. O26

Ek M.L. P22 Ekouévi D. O19, O20 Emery S. O23 Emery V.C. O23 England K. P25

F

Farley T. P13 Faye A. O16 Fenyo E.M. O2, O28 Fiore J.R. O4 Fleury H. O18 Flores G. P12 Flori P. P1 Fonseca R. O1 Freda E.D. P20 French R. O21

G

Gabiano C. P18 Gaillard P. P13 Gangnard S. P9 Garcia Alonso D. P14, P23 Gervaise A. P7 Gessain A. O6 Gesualdo L. O4 Giaquinto C. O2, O25 Gibb D.M. O25 Goetghebuer T. O25, P24 Gonzalez M. O9 Goulder P. O27 Gray G. O20 Greco P. O4 Grinsztejn B. P12 Guessant S. P10 Guibert G. O10

H

(20)

Hinjiranandana T. O12, P5 Hissar S. P2 Honegger J. O8 Horm S.V. P22 Horo A. O19

I

Im S. P22

J

Jasseron C. O16 Jeena P. O27 John-Stewart G. L4, O23 Jolette E. O7 Jourdain G. O12, P5 Juillerat A. P9

K

Kalili R. P12 Kara A. P10 Karlsson I. O2, O28 Karlsson K. O17 Kengne Nouemsi A. P6

Kfutwah A. O14, O18, P9 Khamduang W. O12 Kilewo C. O17 Kowalik-Mikolajewska B. P19 Kozlowski P. O15 Kruy L.S. P22 Kruy Sim L. O20 Krzysztofiak A. P20 Kuijpers T. P17 Kumar G.T. P2

L

Lallemant M. O12 ,P5 Lapointe N. O7, O11 Lazier L. P18

Le Chenadec J. O10, O16, O25 Le Fouler L. O18

Le Tuan P. P11 Leechanachai P. P5 Leke R. O14 Lemen B. O14 Lemercier D. O9 Lemieux M. O15 Lepage C. O11

Leroy V. O19 Leruez-Ville M. O10, P1 Leurent B. O12 Leverger G. P10 Leviton M. P4 Levy J. O25, P24 Lien T.T.X. O18 Li Pira G. P20 Lima E. P12 Lipyoga R. O17 Lira R. O1 Lismerio R. P12 Lopez H. P8 Lot F. P21 Lribeiro J.E. P12 Luzuriaga K. L5 Ly N. O18 Lyamuya E. O17

M

Maes P. P24 Manca F. P20 Mandelbrot L. O10, O16 Mandop EnyegueD. P6 Manoj K. P2 Marcelin A.G. P10 Marcy O. P22 Maréchal V. O18 Marlin R. P7 Marthas M.L. O15 Martinez Peralta L. O13 Mary J.Y. O14 Massawe A. O17 Mathieu O. O26 Matsuda F. O6 Mbori-Ngacha D. O23 McCarthy N. O27 McChesney M.B. O15 McGregor A. P4 McIntosh K. O12 McIntyre J. O20 McVoy M. P4 Melo M. O1

(21)

Mercereau-Puijalon O. P9 Meunier I. O11 Mhalu F. O17 Mignone F. P18 Milliancourt C. O22 Mncube Z. O27 Moore J. O15 Moreau A. P5 Moreira A.M. O1 Morgado M. P12 Morris L. O27 Moss B. O15 Mphatswe W. O27 Msellati P. O26 Msemo G. O17 Munoz-Fernandez M. P14, P23 Muri S. P12

N

Naarding M. O3 Nacro B. O26 Ndayisaba G.F. P15

Nerrienet E. O14, O18, O20, P22

Newell M.L. P17, P25 Ngarina M. O17 Ngin S. P22 Ngo-Giang-Huong N. O12, P5 Ngondi J.L. P6 Nguyen H.B. P11 Nguyen M.A. P11 Nicolas J. O26 Nielsen-Saines K. O1 Nugeyre M.T. P7

O

Oben J. P6 Obimbo E. O23 Omes K.C. P15 Onyango D. L1 Ouiminga A. O26

Paris L. O9 Pauchard M. O9 Paxton W. O3 Payne B.L. O23 Peltier A. P24 Peltier C.A. P15 Pembrey L . P17, P25 Peyrière H. O26 Pillay V. O27 Pillonel J. P21 Pilotto J. P12 Pinget R. P21 Plancoulaine S. O6 Plebani A. O2, O28 Pokorska-Lis M. P19 Pollakis G. O3 Prasad M. O8 Prendergast A. O27 Puja S. P2

R

Rakgotho M. O27 Ranjeet C. P2 Reddy S. O27 Resino R. P23 Reynes J.M. O18 Richardson B. O23 Riegel Santos B. O1 Ripamonti C. O28 Rivière Y. O22 Rodrigues-Pedro A. P12 Romiti M.L. P20 Rose J. O15 Rose N. O15 Rossi P. P20 Rouet F. O26 Rousset D. O14

(22)

Scarlatti G. O2, O28 Schleiss M. P4 Schmidt K. O15 Schmitz V. P24 Schneider V. P10 Scolfaro C. P18 Scott-Algara D. O22, P7 Segeral O. P22 Semaille C. P21 Shiv K S. P2 Simonetti A. P20 Sirinontakan S. O12 Sirirungsi W. O12 Slyker J.A. O23 Solana M.E. O13 Somsamai R. O12 Soudeyns H. O7, O11 Speijer D. O3 Stax M. O3 Suraseranivong V. P5 Swai A. O17 Syed N K. P2

T

Tabone M.D. P10 Tamboura H. O26 Teglas J.P. O10, O16 Thobakgale C. O27 Thorne C. P25 Tortevoye P. O6 Touafek L. O9 Touré P. O19 Touwe-Gold B. O19 Tovo P.A. L7, P16, P18 Tremblay M.J. O5 Troesch M. O11

Tubiana R. O9, O10, O16, P10 Tudor-Williams G. O27

Turella M.L. O1

U

Ung V. P22

V

Van de Perre P. L2, O26 Van der Linden D. P24 Van Rompay K.K. O15

Vanderstok M. O27 Varella I. O1 Vasilescu A. O6 Vatrano S. P16 Vaudre G. P10 Veloso V. P12 Versace A. P16, P18 Véssière A. O18 Vidricaire G. O5 Ville Y. P1 Vray M. O18

W

Walker B.D. O27 Walker C. O8 Warachit B. P5 Warning J. O21

Warszawski J. O10, O16, O24, O25

Y

Yaméogo S. O26

Z

(23)

C

ONGRESS

O

FFICE

VBCE – DDIC